Advertisement
Advertisement
January 5, 2021
Inari Medical Appoints VPs of Medical Affairs and Inari Solutions Group
January 5, 2021—Inari Medical, Inc. announced the appointment of Venkat Tummala, MD, to Vice President, Medical Affairs, and Justin Crockett to Vice President, Inari Solutions Group.
According to the company, Dr. Tummala joins the company from Radiology and Imaging Specialists of Lakeland, Florida, where he was in practice for 10 years. He obtained his medical degree at Guntur Medical College in Guntur, India, and completed postgraduate training at University of Miami in Miami, Florida; Michigan State University in East Lansing, Michigan; and University of South Florida in Tampa, Florida.
Additionally, the company noted that Justin Crockett will be leading the Inari Solutions Group, which is dedicated to helping hospitals develop clinical programs to identify, triage, and treat patients with venous thromboembolism. Previously, he was Vice President of United States Healthcare Solutions for the Watchman franchise at Boston Scientific. Mr. Crockett obtained his doctor of health administration from the Medical University of South Carolina in Charleston, South Carolina.
Thomas Tu, MD, Inari’s Chief Medical Officer, commented in the announcement, “Venkat is a master operator in the field of interventional radiology and a leader in physician education. We are honored to have him add his talents to our team.” Dr. Tu continued, “Justin has a proven track record of helping hospitals develop systems and processes that optimize patient outcomes for disease states being transformed by new technology. The field of venous thromboembolism will greatly benefit from his efforts.”
Inari Medical has developed two minimally invasive, novel catheter-based mechanical thrombectomy devices that are designed for the treatment of the two distinct manifestations of venous thromboembolism. The ClotTriever system received FDA 510(k) clearance for the treatment of deep vein thrombosis. The FlowTriever system is cleared for the treatment of pulmonary embolism.
Advertisement
Advertisement